Collectively, the above findings suggest that SNHG4 promotes HCC malignancy through the SNHG4/miR‐211‐5p/CREB5 axis, providing potential therapeutic targets and prognostic factors for HCC. The gene discussed is CREB5; the disease is hepatocellular carcinoma.